Eloxx Pharmaceuticals Company Profile Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eloxx pharmaceuticals company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eloxx Pharmaceuticals Company Profile Get Rating Today - Breaking & Trending Today

Eloxx Pharmaceuticals (NASDAQ:ELOX) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Rating) from a hold rating to a buy rating in a research note published on Monday morning, Zacks.com reports. The brokerage currently has $0.75 target price on the stock. According to Zacks, “Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing […] ....

United States , Analyst Recommendations For Eloxx Pharmaceuticals , Eloxx Pharmaceuticals , Eloxx Pharmaceuticals Company Profile Get Rating , Zacks Investment Research , Eloxx Pharmaceuticals Inc , Sevion Therapeutics Inc , Millennium Management , Get Rating , Capital Wealth Advisors , Capital Management , Two Sigma Advisers , Sigma Advisers , Pharmaceuticals Company Profile , Nasdaq Elox ,